Epidemic and pandemic-prone diseases: 2020 in retrospect

In 2020, the world had experienced one of the most devastating pandemics in recent history. The current COVID-19 pandemic is simply more than a health crisis, and it is affecting the lives, economies and livelihoods of billions of people around the world. This new virus is unprecedented in our lives and demands that the international community works together in solidarity to control the pandemic and its devastating consequences.

The first cases of COVID-19 were reported in the Eastern Mediterranean Region on 29 January 2020 among travellers coming from Wuhan, China. In 10 weeks, the virus had spread to all 22 countries and territories, despite collective efforts by Member States to implement strict public health and social measures. By the end of the year, approximately 5 million cases had been reported, including 121 778 associated deaths from all 22 countries of the Region, revealing a case–fatality ratio (CFR) of 2.5%. Islamic Republic of Iran registered the highest number of cases and fatalities, followed by Iraq and Pakistan.

WHO continues to support countries of the Region to scale up their preparedness and response interventions and bring the COVID-19 pandemic under control. Besides the pandemic, WHO continued to support countries in the Region to enhance their capacities to prevent, prepare for, detect and respond to other public health threats posed by emerging and pandemic-prone diseases. In 2020, 10 major outbreaks by other emerging infectious diseases occurred in 7 countries of the Region, including poliomyelitis in Afghanistan and Pakistan; chikungunya in Somalia and Sudan; cholera in Somalia and Yemen; dengue fever in Pakistan and Yemen; diphtheria in Sudan and Yemen; Crimean-Congo haemorrhagic fever in Afghanistan and Pakistan; chickenpox (varicella) in Pakistan; Middle East respiratory syndrome (MERS) in Saudi Arabia; and viral haemorrhagic fever in Sudan.

The WHO Health Emergencies programme (WHE) in the WHO Regional Office for the Eastern Mediterranean has led the pandemic response, while coordinating with other departments within the regional and country offices.

In 2020, WHO worked closely with Member States in the Region to:

lead the incident management system to better coordinate and support the COVID-19 response across the Region;

support countries in the Region to re-activate and maintain surveillance for severe acute respiratory infections (SARI) and influenza-like illnesses (ILI) while appropriately leveraging it for COVID-19 surveillance;

support Member States to improve their critical care and intensive care unit (ICU) capacities through mentoring, surge support and provision of supplies to better manage severe and critical COVID-19 patients at referral hospitals;

contribute to efforts by the Regional Office to support and build national capacities by running modelling and forecasting analyses that will guide governments’ strategies to limit disease transmission and implement appropriate public health and social measure interventions;

support the expansion and strengthening of public and private laboratory diagnostic capacities using reverse-transcriptase polymerase chain reaction (RT-PCR) across the Region;

continue to support Member States to build their laboratories capacities across different diagnostic capabilities for high-threat pathogens in line with International Health Regulations (IHR 2005);

support the expansion and strengthening of surveillance through the Early Warning Alert and Response Network (EWARN) in conflict and emergency settings, particularly in Libya and Yemen;

continue to build the capacities of national and subnational rapid response teams in outbreak investigation and response in the context of COVID-19, with over 300 trained virtually in Libya, north-east Syria, Pakistan, Saudi Arabia, Somalia, Sudan and Yemen;

maintain the production and dissemination of flagship publications to analyse the ongoing outbreaks and other important public health events, including Weekly Epidemiological Monitors, and weekly and monthly disease-specific bulletins;

coordinate Regional Office support for ongoing outbreak investigation and response to arboviral and zoonotic disease outbreaks in Sudan, Yemen and other countries, including the improvement of clinical management support in viral haemorrhagic fevers (e.g. dengue, Rift Valley fever, chikungunya, and Crimean-Congo haemorrhagic fever;

continue to contribute to risk communication and community engagement activities against the COVID-19 pandemic by developing messaging and producing communication products that simplify WHO guidance and address misinformation about the disease;

maintain an online presence through the website of the WHO Regional Office for the Eastern Mediterranean and continue to update visitors on active disease outbreaks, including COVID-19, MERS, cholera and influenza;

address gaps in knowledge, produce knowledge products and gather evidence and best practices and share those to help front-line health workers prevent and control emerging diseases.

1 / 15

Presentations and discussions during the EWARN evaluation workshop. Credit: WHO

Evaluating Libya’s surveillance system

WHO organized a workshop that aimed to start a systematic evaluation of Libya’s early warning alert and response network (EWARN) surveillance system and ensure that the system was effectively meeting its objectives. The workshop, which took place in Tunisia in January 2020, provided an overview of the evaluation protocol and agreed on a road map for conducting the evaluation. A total of 10 senior surveillance officers attended the workshop, including the EWARN coordinator and 7 surveillance officers from the National Centre for Disease Control. Representatives from the International Organization for Migration and the International Medical Corps, partners reporting to the EWARN system, were also included in this training. Participants were briefed on the evaluation protocol and the evaluation methodology was discussed in detail. Presentations and discussions on the standard evaluation protocol for EWARN were undertaken, and previous experiences with the evaluation carried out in different countries were shared as practical examples.